Syndicated Research Studies

The global medical instrument washing & disinfection market was valued at USD 7.01 billion in 2024 and is projected to reach USD 11.82 billion by 2033, expanding at a CAGR of 6.1% from 2025 to 2033. Market growth is strongly driven by rising surgical and endoscopy procedure volumes, a growing emphasis on reducing hospital-acquired infections (HAIs), and the enforcement of stringent global reprocessing standards, including ISO 15883 and AAMI guidelines. These regulations highlight the need for validated, automated systems capable of ensuring consistent cleaning and disinfection results. As surgical instruments become more complex—particularly with the increasing use of robotic tools and lumened devices—healthcare facilities are investing in advanced washer-disinfectors, ultrasonic cleaners, and automated endoscope reprocessors (AERs). Hospitals are also prioritizing digital connectivity, improved traceability, and energy-efficient systems to strengthen compliance, strea...

The global medical devices reimbursement market was valued at USD 777.64 billion in 2024 and is projected to reach USD 1171.72 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. Market expansion is driven by the rising prevalence of chronic cardiovascular conditions and rapid technological advancements in medical devices that require structured reimbursement processes. As chronic disease rates continue to climb, health systems worldwide are increasingly prioritizing reimbursement frameworks that ensure patient access to essential medical technologies. According to the World Health Organization’s World Health Statistics 2024 report, Noncommunicable Diseases (NCDs) account for about 71% of all global deaths, with cardiovascular diseases alone causing 17.9 million deaths annually. This significant disease burden has propelled demand for medical devices such as cardiac monitors, insulin pumps, and dialysis machines. As utilization of these devices increases, the need for ...

The global  medical devices reimbursement market  size is expected to reach USD 1,171.72 billion by 2030, expanding at a CAGR of 7.07% from 2025 to 2030, according to a new report by Grand View Research, Inc. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them. For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted proced...